OB:NYKDBiotechs
What You Need To Know About Nykode Therapeutics AS' (OB:NYKD) Investor Composition
If you want to know who really controls Nykode Therapeutics AS ( OB:NYKD ), then you'll have to look at the makeup of...
OB:ULTIBiotechs
Ultimovacs ASA's (OB:ULTI) market cap dropped kr277m last week; individual investors who hold 36% were hit as were institutions
A look at the shareholders of Ultimovacs ASA ( OB:ULTI ) can tell us which group is most powerful. We can see that...
OB:BGBIOBiotechs
Will BerGenBio (OB:BGBIO) Spend Its Cash Wisely?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
OB:ULTIBiotechs
Ultimovacs (OB:ULTI) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
OB:NANOVBiotechs
Is Nordic Nanovector ASA (OB:NANOV) Popular Amongst Institutions?
A look at the shareholders of Nordic Nanovector ASA ( OB:NANOV ) can tell us which group is most powerful. Generally...
OB:TRVXBiotechs
Insiders who bought this year lost kr121k as Targovax ASA (OB:TRVX) sheds kr38m in value
The recent 12% drop in Targovax ASA's ( OB:TRVX ) stock could come as a blow to insiders who purchased kr414k worth of...
OB:NYKDBiotechs
Nykode Therapeutics AS' (OB:NYKD)) market cap declines to kr8.2b but insiders who sold US$133m stock were able to hedge their losses
Over the past year, insiders sold US$133m worth of Nykode Therapeutics AS ( OB:NYKD ) stock at an average price of...
OB:HBCBiotechs
The Chief Executive Officer of Hofseth BioCare ASA (OB:HBC), Roger Hofseth, Just Bought A Few More Shares
Even if it's not a huge purchase, we think it was good to see that Roger Hofseth, the Chief Executive Officer of...
OB:BGBIOBiotechs
Insiders who bought in the last 12 months lose an additional kr87k as BerGenBio ASA (OB:BGBIO) drops to kr1.4b
Insiders who bought kr391k worth of BerGenBio ASA's ( OB:BGBIO ) stock at an average buy price of kr20.47 over the last...